Literature DB >> 7717877

Stimulation of myosin light-chain kinase by Cd2+ and Pb2+.

S H Chao1, C H Bu, W Y Cheung.   

Abstract

The effect of Cd2+ on myosin light chain kinase (MLCK) reported in the literature is controversial, apparently because the level of Ca2+ contaminating the reaction mixture could not be accurately controlled by the addition of a metal chelator when Cd2+ was also present. In the present study, we have reduced the contaminating Ca2+ to a trace level that did not interfere with the enzyme activity; thus the use of a metal chelator was not necessary. We showed that Cd2+, or Pb2+ had a biphasic effect on MLCK isolated from chicken gizzard: stimulation at low and inhibition at high concentrations. (The stimulatory effect of on the enzyme activity isolated from chicken gizzard: stimulation at low and inhibition at high concentrations). The stimulatory effect of Cd2+ or Pb2+ on MLCK activity was not seen in the absence of calmodulin, and was abolished by trifluoperazine, a calmodulin antagonist, indicating that the heavy metals exert their activation via calmodulin. The inhibition of the enzyme activity by Cd2+ or Pb2+ at higher concentrations was also seen with the calmodulin-independent catalytic fragment of MLCK, suggesting that the inhibition is probably through their binding to sulfhydryl groups that are essential for catalytic activity. Pb2+ was more effective than Cd2+ in stimulating the enzyme activity, but less potent in inhibition. The extent of stimulation by heavy metals most likely resulted from a combination of the biphasic effects. Dithiothreitol and N,N,N',N'-tetrakis (2-pyridylmethyl) ethylenediamine selectively chelated Cd2+ and Pb2+ over Ca2+, and reversed their stimulatory or inhibitory effect on MLCK.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717877     DOI: 10.1007/s002040050158

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  28 in total

Review 1.  The function of myosin and myosin light chain kinase phosphorylation in smooth muscle.

Authors:  K E Kamm; J T Stull
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

2.  Cadmium inhibits plasma membrane calcium transport.

Authors:  P M Verbost; G Flik; R A Lock; S E Wendelaar Bonga
Journal:  J Membr Biol       Date:  1988-05       Impact factor: 1.843

3.  Autoregulation of enzymes by pseudosubstrate prototopes: myosin light chain kinase.

Authors:  R B Pearson; R E Wettenhall; A R Means; D J Hartshorne; B E Kemp
Journal:  Science       Date:  1988-08-19       Impact factor: 47.728

4.  Tissue concentration of cadmium, zinc and copper from autopsy samples.

Authors:  J M McKenzie
Journal:  N Z Med J       Date:  1974-06-12

5.  Isolation of the native form of chicken gizzard myosin light-chain kinase.

Authors:  P K Ngai; C A Carruthers; M P Walsh
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

6.  Purification and characterization of smooth muscle myosin light chain kinase.

Authors:  R S Adelstein; C B Klee
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

7.  Selective purification of the 20,000-Da light chains of smooth muscle myosin.

Authors:  D R Hathaway; J R Haeberle
Journal:  Anal Biochem       Date:  1983-11       Impact factor: 3.365

8.  Proteolysis of smooth muscle myosin light chain kinase. Formation of inactive and calmodulin-independent fragments.

Authors:  M Ikebe; M Stepinska; B E Kemp; A R Means; D J Hartshorne
Journal:  J Biol Chem       Date:  1987-10-05       Impact factor: 5.157

9.  Detection of two classes of Ca2+ binding sites in troponin C with circular dichroism and tyrosine fluorescence.

Authors:  J D Johnson; J D Potter
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

10.  Cytosolic Ca2+ homeostasis in Ehrlich and Yoshida carcinomas. A new, membrane-permeant chelator of heavy metals reveals that these ascites tumor cell lines have normal cytosolic free Ca2+.

Authors:  P Arslan; F Di Virgilio; M Beltrame; R Y Tsien; T Pozzan
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

View more
  8 in total

1.  A structural insight into lead neurotoxicity and calmodulin activation by heavy metals.

Authors:  Petri Kursula; Viivi Majava
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-28

2.  Lead(II) Binding in Natural and Artificial Proteins.

Authors:  Virginia Cangelosi; Leela Ruckthong; Vincent L Pecoraro
Journal:  Met Ions Life Sci       Date:  2017-04-10

Review 3.  Defining potential roles of Pb(2+) in neurotoxicity from a calciomics approach.

Authors:  Rakshya Gorkhali; Kenneth Huang; Michael Kirberger; Jenny J Yang
Journal:  Metallomics       Date:  2016-06-01       Impact factor: 4.526

4.  Mammalian metal response element-binding transcription factor-1 functions as a zinc sensor in yeast, but not as a sensor of cadmium or oxidative stress.

Authors:  Patrick J Daniels; Doug Bittel; Irina V Smirnova; Dennis R Winge; Glen K Andrews
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

5.  Structural differences between Pb2+- and Ca2+-binding sites in proteins: implications with respect to toxicity.

Authors:  Michael Kirberger; Jenny J Yang
Journal:  J Inorg Biochem       Date:  2008-07-05       Impact factor: 4.155

6.  The (1)H NMR structure of bovine Pb(2+)-osteocalcin and implications for lead toxicity.

Authors:  T L Dowd; L Li; C M Gundberg
Journal:  Biochim Biophys Acta       Date:  2008-08-27

7.  Metal toxicity and opportunistic binding of Pb(2+) in proteins.

Authors:  Michael Kirberger; Hing C Wong; Jie Jiang; Jenny J Yang
Journal:  J Inorg Biochem       Date:  2013-04-19       Impact factor: 4.155

8.  Flexibility of EF-hand motifs: structural and thermodynamic studies of Calcium Binding Protein-1 from Entamoeba histolytica with Pb2+, Ba2+, and Sr2+.

Authors:  Shivesh Kumar; Ejaz Ahmad; Sanjeev Kumar; Rizwan Hasan Khan; Samudrala Gourinath
Journal:  BMC Biophys       Date:  2012-08-20       Impact factor: 4.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.